Search JIM Advanced Search

Journal of Integrative Medicine ›› 2014, Vol. 12 ›› Issue (3): 175-181.doi: 10.1016/S2095-4964(14)60028-5

• Study Protocol • Previous Articles     Next Articles

Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: Protocol for a randomized double-blind controlled trial

Zhi-yi Zhoua, Ling Xua, He-gen Lia, Jian-hui Tiana, Li-jing Jiaoa, Sheng-fu Youa, Zhi-fen Hanb, Yi Jianga, Hui-ru Guoa, Hui Liub   

  1. Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
    Department of Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China
  • Received:2014-04-09 Accepted:2014-04-15 Online:2014-05-10 Published:2014-05-15


Traditional Chinese medicine (TCM) is considered an important complementary therapy with beneficial effects for cancer patients. Elderly patients with non-small-cell lung cancer (NSCLC) are a complex patient group with increasing co-morbidity and shrinking physiological reserve, and may derive substantial benefit from the supportive aspects of TCM. Researchers from Shanghai Longhua Hospital found that qi and yin deficiency is a common syndrome in patients with stage III or IV lung cancer. This project was designed to study the combination of single-agent chemotherapy with TCM methods of benefiting qi and yin in elderly patients with advanced NSCLC.

Methods and design

This is a double-blind controlled, multi-center, and prospective study with randomly selected participants from elderly NSCLC patients in China. Seventy-six patients who meet the inclusion criteria will be allocated into two groups, which will receive treatments of 3-week single-agent chemotherapy with TCM or placebo for four cycles. Progression-free survival (PFS) is the primary end point, and the secondary end points are overall survival, objective response rate, time-to-progression, and quality of life (EORTC QLQ-LC43, and TCM syndrome score). Meanwhile, other end points such as toxicity, side effects and safety of the treatments will be assessed.


Results from this study may provide evidence on the effectiveness, and parameters for the usage of single-agent chemotherapy combined with or without TCM on PFS of elderly patients with NSCLC.

Trial Registration (Identifier: NCT01780181).

Key words: Non-small-cell lung carcinomas, Chemotherapy, Traditional medicine, Chinese, progression-free survival, Randomized controlled trials, Study protocol

Figure 1

Flow diagram of the study ^ PFS: progression-free survival; OS: overall survival; ORR: objective response rate; TTP: time-to-progression; QOL: quality of life."

[1] U.S.National Cancer Institute. Previous version: SEER cancer statistics review, 1975-2010. (2013-06-14)[ 2013-09-06]. .
[2] Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ . Cancer statistics, 2007[J]. CA Cancer J Clin, 2007,57(1):43-66
doi: 10.3322/canjclin.57.1.43
[3] Wingo PA, Cardinez CJ, Landis SH, Greenlee RT, Ries LA, Anderson RN, Thun MJ . Long-term trends in cancer mortality in the United States, 1930-1998[J]. Cancer, 2003,97(12 Suppl):3133-3275
doi: 10.1002/(ISSN)1097-0142
[4] Ruano-Ravina A, Pérez-Becerra R, Fraga M, Kelsey KT, Barros-Dios JM . Analysis of the relationship between p53 immunohistochemical expression and risk factors for lung cancer, with special emphasis on residential radon exposure[J]. Ann Oncol, 2008,19(1):109-114
[5] Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, Wingo PA, Jemal A, Feigal EG . Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden[J]. Cancer, 2002,94(10):2766-2792
doi: 10.1002/(ISSN)1097-0142
[6] Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E, Ramalingam SS . Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database[J]. J Clin Oncol, 2007,25(35):5570-5577
doi: 10.1200/JCO.2007.12.5435
[7] Srenson S1, Glimelius B, Nygren P; SBU-group. A systematic overview of chemotherapy effects in non-small cell lung cancer[J]. Acta Oncol, 2001,40(2-3):327-339
doi: 10.1080/02841860120014
[8] Davidoff AJ, Tang M, Seal B, Edelman MJ . Chemotherapy and survival benefit in elderly patients with non-small-cell lung cancer[J]. J Clin Oncol, 2010,28(13):2191-2197
doi: 10.1200/JCO.2009.25.4052
[9] Gridelli C, Perrone F, Gallo C, Cigolari S, Rossi A, Piantedosi F, Barbera S, Ferraù F, Piazza E, Rosetti F, Clerici M, Bertetto O, Robbiati SF, Frontini L, Sacco C, Castiglione F, Favaretto A, Novello S, Migliorino MR, Gasparini G, Galetta D, Iaffaioli RV, Gebbia V; MILES Investigators.Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study(MILES) phase III randomized trial[J]. J Natl Cancer Inst, 2003,95(5):362-372
doi: 10.1093/jnci/95.5.362
[10] The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer[J]. J Natl Cancer Inst, 1999,91(1):66-72
doi: 10.1093/jnci/91.1.66
[11] Ricci S, Antonuzzo A, Galli L, Tibaldi C, Bertuccelli M, Lopes Pegna A, Petruzzelli S, Algeri R, Bonifazi V, Fioretto ML, Orlandini C, Conte PF . Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study[J]. Lung Cancer, 2000,27(2):75-80
doi: 10.1016/S0169-5002(99)00098-7
[12] Bianco V, Rozzi A, Tonini G, Santini D, Magnolfi E, Vincenzi B , D’Angelillo R, Marchei P.Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer(NSCLC): a phase II study[J]. Anticancer Res, 2002,22(5):3053-3056
[13] Pallis AG , Gridelli C, van Meerbeeck JP, Greillier L, Wedding U, Lacombe D, Welch J, Belani CP, Aapro M.EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology(SIOG) experts’ opinion for the treatment of non-small-cell lung cancer in an elderly population[J]. Ann Oncol, 2010,21(4):692-706
doi: 10.1093/annonc/mdp360
[14] Kudoh S, Takeda K, Nakagawa K, Takada M, Katakami N, Matsui K, Shinkai T, Sawa T, Goto I, Semba H, Seto T, Ando M, Satoh T, Yoshimura N, Negoro S, Fukuoka M . Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial(WJTOG 9904)[J]. J Clin Oncol, 2006,24(22):3657-3663
doi: 10.1200/JCO.2006.06.1044
[15] Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, Baker S Jr, Olak J, Stover D, Strawn JR, Turrisi AT, Somerfield MR . American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003[J]. J Clin Oncol, 2004,22(2):330-353
doi: 10.1200/JCO.2004.09.053
[16] Gridelli C, Aapro M, Ardizzoni A, Balducci L, De Marinis F, Kelly K, Le Chevalier T, Manegold C, Perrone F, Rosell R, Shepherd F, De Petris L, Di Maio M, Langer C . Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel[J]. J Clin Oncol, 2005,23(13):3125-3137
doi: 10.1200/JCO.2005.00.224
[17] National Collaborating Centre for Acute Care. Lung cancer: the diagnosis and treatment of lung cancer. London: National Institute for Clinical Excellence. 2005.
[18] Zheng XY. The guiding principles of clinical research of new Chinese medicine (trial). Beijing: Chinese Medical Science and Technology Press. 2002. Chinese.
[19] Shanghai Municipal Public Health Bureau. Shanghai diagnosis and treatment routine of TCM syndrome. 2nd ed. Shanghai: Shanghai University of Traditional Chinese Medicine Press. 2003. Chinese.
[20] Wan C, Zhang C, Tu X, Feng C, Tang W, Luo J, Meng Q . Validation of the simplified Chinese version of the quality of life instrument EORTC QLQ-LC43 for patients with lung cancer[J]. Cancer Invest, 2008,26(5):504-510
doi: 10.1080/07357900701781788
[21] National Cancer Institute. Common terminology criteria for adverse events v3.0 (CTCAE). (2006-08-09)[ 2013-09-06]. .
[22] Liu JX, Mao L, Yang PL, Qiu JL, Xu LF, Zhao YR, Yu XZ, Xiang RY . Clinical observation on 200 cases of lung cancer patients based on traditional Chinese medicine syndrome differentiation[J]. Zhong Liu Fang Zhi Yan Jiu, 1978,2:48-57
[23] Liu JX . Treatment of 310 primary lung cancer patients based on traditional Chinese medicine syndrome differentiation[J]. Shanghai Zhong Yi Yao Za Zhi, 1985,10:3-6
[24] Liu JX, Xu ZY, Shi ZM, Guo YH, Fan ZZ, Li MH, Huang JM, Zhu YW, Zhao LH, Shi CM, Gao H, Chen SX . Strengthening body resistance method in the treatment of 122 patients with advanced non-small cell lung cancer: a prospective study[J]. Zhongguo Yi Yao Xue Bao, 1987,2(1):11-16
[25] Liu JX . Clinical and experimental research on strengthening body resistance method in the treatment of advanced primary lung adenocarcinoma[J]. Zhong Liu Fang Zhi Yan Jiu, 1990,17(2):129
[26] Xu ZY, Liu JX, Han MQ, Zhu YW, Zhao LH, Shi ZM, Gao H, Chen SX . Yin-Yang balancing therapy of traditional Chinese medicine for cancer: an effect analysis of 112 cases of advanced cancer patients with more than one year survival[J]. Shanghai Zhong Yi Yao Za Zhi, 1992,3:10-12
[27] Liu JX, Shi ZM, Xu ZY, Han MQ, Zhu YW, Gao H, Chen SX, Zhao LH, Li HG, Zhu HR, Liu LS . Studies on late primary adenocarcinoma of lung treated by methods of nourishing yin to replenish fluid and warming yang to benefit qi[J]. Zhong Yi Za Zhi, 1995,36(3):155-158
[28] Liu JX, Pan MQ, Li YH, Ye DX, Guo YH, Li YJ . Clinical study of Jin Fu Kang oral liquid for treating non-small cell lung cancer[J]. Zhong Liu, 2001,21(6):488-491
[29] Liu JX, Shi ZM, Li HG, Xu ZY, Zhu YW, Zhao LH, Gao H, Liu LS, Zhu HR, Zhang H . Study of Yifei Kangliu decoction for 271 non-small cell lung cancer patients[J]. Yi Xue Yan Jiu Tong Xun, 2003,32(3):23-24
[30] Guo H, Liu JX, Xu L, Madebo T, Baak JP . Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapy[J]. Integr Cancer Ther, 2011,10(2):127-137
doi: 10.1177/1534735410387599
[31] You J, Shan MJ, Zhao H . Clinical study of integrative treatment for ninety-one elderly patients with advanced non-small cell lung cancer[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2012,32(6):774-778
[32] Liu LS, Jiang Y, Shen LP, Han ZF, Fan YL, Li HG . Survival analysis of elderly patients with advanced non-small cell lung cancer received traditional Chinese medicine intervention[J]. Shanghai Zhong Yi Yao Da Xue Xue Bao, 2011,25(6):774-778
[33] Moher D, Hopewell S, Schulz KF, Montori V , G?tzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG; Consolidated Standards of Reporting Trials Group.CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials[J]. J Clin Epidemiol, 2010,63(8):e1-37
doi: 10.1016/j.jclinepi.2010.03.004
[1] Xin-yu Yue, Zhuo-qi Feng, Xi-yi Yu, Jia-min Hu, Xiao-Jing He, Shi Shu. Fire-needle acupuncture for upper limb spastic paralysis after stroke: Study protocol for a randomized controlled trial. Journal of Integrative Medicine, 2019, 17(3): 167-172.
[2] Ya-ru Huangfu, Wei Peng, Bao-jun Guo, Zhi-fu Shen, Li Li, Shi-wei, Liu, Hui Zheng, You-ping Hu. Effects of acupuncture in treating insomnia due to spleen-stomach disharmony syndrome and its influence on intestinal microbiome: Study protocol for a randomized controlled trial. Journal of Integrative Medicine, 2019, 17(3): 161-167.
[3] Arthur Yin Fan, Sarah F. Alemi, Yingping H. Zhu, Sudaba Rahimi, Hui Wei, Haihe Tian, Deguang He, Changzhen Gong, Guanhu Yang, Chong He, Hui Ouyang . Effectiveness of two different acupuncture strategies in patients with vulvodynia: Study protocol for a pilot pragmatic controlled trial. Journal of Integrative Medicine, 2018, 16(6): 384-389.
[4] Marco Cascella, Maria Rosaria Muzio. Potential application of the Kampo medicine goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy. Journal of Integrative Medicine, 2017, 15(2): 77-87.
[5] Susana Seca, Sebastian Kirch, António S.Cabrita, Henry J.Greten. Evaluation of the effect of acupuncture on hand pain, functional deficits and health-related quality of life in patients with rheumatoid arthritis—A study protocol for a multicenter, double-blind, randomized clinical trial. Journal of Integrative Medicine, 2016, 14(3): 219-227.
[6] Maria T.Chao, AlexandraChang, SanjayReddy, James D.Harrison, JosephAcquah, MiriaToveg, TrilceSantana, Frederick M.Hecht. Adjunctive acupuncture for pain and symptom management in the inpatient setting: Protocol for a pilot hybrid effectiveness-implementation study. Journal of Integrative Medicine, 2016, 14(3): 228-238.
[7] Nouran A. Aleyeidi, Khaled S. Aseri, Shadia M. Matbouli, Albaraa A. Sulaiamani, Sumayyah A. Kobeisy. Effects of wet-cupping on blood pressure in hypertensive patients: A randomized controlled trial. Journal of Integrative Medicine, 2015, 13(6): 391-399.
[8] Jessica Stanhope, Philip Weinstein, Angus Cook. Health effects of natural spring waters: A protocol for systematic reviews with a regional case example. Journal of Integrative Medicine, 2015, 13(6): 416-420.
[9] Ya Yuwen, Yu-qi Liu, Yan-ping Wang, Jin-gang Dai, Da-sheng Liu, Yue-xi Wang, Xue-jie Han. The add-on effect of a Chinese herbal formula for patients with resistant hypertension: Study protocol for a pilot cohort study. Journal of Integrative Medicine, 2015, 13(2): 122-128.
[10] Meng-yue Liu, Cheng-wei Wang, Zhou-peng Wu, Ning Li. Electroacupuncture for the prevention of postoperative gastrointestinal dysfunction in patients undergoing vascular surgery under general anesthesia: Study protocol for a prospective practical randomized controlled trial. Journal of Integrative Medicine, 2014, 12(6): 512-519.
[11] Zhong-liang Liu, Wei-rong Zhu, Wen-chao Zhou, Hai-feng Ying, Lan Zheng, Yuan-biao Guo, Jing-xian Chen, Xiao-heng Shen. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: A systematic review and meta-analysis. Journal of Integrative Medicine, 2014, 12(4): 346-358.
[12] Jian Liu, Chuan-bing Huang, Yuan Wang, Gui-qin Xu, Yuan-yuan Cheng, Yun-xia Feng, Lei Liu, Ya-jun Qi. Chinese herbal medicine Xinfeng Capsule in treatment of rheumatoid arthritis: Study protocol of a multicenter randomized controlled trial. Journal of Integrative Medicine, 2013, 11(6): 428-434.
[13] Tian-zhan Wang, Yu Chen, Yan-ming He, Xiao-dong Fu, Wang Yi, Yan-qiu Xu, Hong-jie Yang, Hong-li Xue, Yi Liu, Xiao-tao Feng, Teng Zhang, Wen-jian Wang. Effects of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trial. Journal of Integrative Medicine, 2013, 11(3): 175-183.
[14] Xue-qing Yu, Jian-sheng Li, Su-yun Li, Yang Xie, Ming-hang Wang, Hai-long Zhang, Hai-feng Wang, Zhi-wan Wang. Functional and psychosocial effects of pulmonary Daoyin on patients with COPD in China: Study protocol of a multicenter randomized controlled trial. Journal of Integrative Medicine, 2013, 11(2): 140-146.
[15] Chung-wah Cheng, Shu-fei Fu, Qing-hui Zhou, Tai-xiang Wu, Hong-cai Shang, Xu-dong Tang, Zhi-shun Liu, Jia Liu, Zhi-xiu Lin, Lixing Lao, Ai-ping Lü, Bo-li Zhang, Bao-yan Liu, Zhao-xiang Bian. Extending the CONSORT Statement to moxibustion. Journal of Integrative Medicine, 2013, 11(1): 54-63.
Full text



[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[5] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[6] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[7] Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[8] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[9] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[10] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013